Advertisement
Screener

PULMONX CORPORATION (LUNG) Graph

LUNG Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $22.76M; Cost of revenue $5.01M; Research and development $5.03M; Selling, general and administrative $21.77M.
  • 2026-03-31: Revenue $20.59M; Cost of revenue $4.54M; Research and development $4.90M; Selling, general and administrative $24.10M.
  • 2025-12-31: Revenue $22.60M*; Cost of revenue $5.06M*; Research and development $4.58M*; Selling, general and administrative $22.86M*.
  • 2025-09-30: Revenue $21.50M; Cost of revenue $5.45M; Research and development $4.85M; Selling, general and administrative $25.60M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

LUNG revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Asia Pacific$726.00KEMEA$7.73MOther InternationalGeographical Areas$126.00KUS$14.18MRevenue$22.76MCost of revenue$5.01MGross profit$17.74MOperating expenses$26.80MOperating income-$9.06MOther income, net-$1.00KResearch & development$5.03MSelling, general& administrative$21.76MPre-tax income-$9.95MNet income-$10.08M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$22.76M$5.01M$5.03M$21.77M$26.80M$133.00K-$10.08M
2026-03-31$20.59M$4.54M$4.90M$24.10M$29.00M$149.00K-$13.65M
2025-12-31$22.60M*$5.06M*$4.58M*$22.86M*$27.44M*$186.00K*-$10.42M*
2025-09-30$21.50M$5.45M$4.85M$25.60M$30.45M$128.00K-$13.96M
2025-06-30$23.86M$6.66M$5.31M$26.70M$32.01M$177.00K-$15.17M
2025-03-31$22.54M$6.20M$4.76M$26.15M$30.91M$135.00K-$14.45M
2024-09-30$20.39M$5.36M$3.74M$25.41M$29.16M$192.00K-$14.14M
2024-06-30$20.78M$5.48M$5.62M$25.31M$30.93M$84.00K-$15.33M
2024-03-31$18.85M$4.78M$4.21M$24.40M$28.61M$186.00K-$13.75M
2023-09-30$17.67M$4.64M$4.22M$23.98M$28.20M$59.00K-$14.90M
2023-06-30$17.19M$4.46M$5.71M$23.46M$29.17M$140.00K-$16.20M
2023-03-31$14.54M$3.95M$4.25M$22.74M$26.99M$124.00K-$15.86M
2022-09-30$13.50M$3.35M$4.37M$19.72M$24.08M$0.00-$14.17M
2022-06-30$13.95M$3.53M$3.59M$21.23M$24.83M$40.00K-$14.64M
2022-03-31$10.79M$2.67M$3.53M$20.25M$23.78M$67.00K-$15.83M
2021-09-30$13.26M$3.52M$2.81M$16.69M$19.50M$44.00K-$10.18M
2021-06-30$12.20M$3.17M$3.51M$18.20M$21.71M$80.00K-$12.96M
2021-03-31$9.24M$2.63M$3.03M$16.07M$19.11M$67.00K-$12.51M
2020-12-31$9.83M(m)(m)(m)(m)(m)-$9.30M
2020-09-30$10.61M$3.15M$2.00M$10.81M$12.81M$49.00K-$3.86M
2020-06-30$3.67M$2.66M$1.43M$11.11M$12.54M$56.00K-$11.91M
2020-03-31$8.62M$2.97M$1.56M$10.19M$11.75M$87.00K-$7.16M
2019-12-31$10.35M(m)(m)(m)(m)(m)-$4.67M
2019-09-30$9.10M$2.70M$1.40M$8.62M$10.02M$89.00K-$4.33M
2019-06-30$7.37M(m)(m)(m)(m)(m)-$5.57M
2019-03-31$5.78M(m)(m)(m)(m)(m)-$6.13M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$43.34M$9.56M$9.93M$45.87M$55.80M$282.00K-$23.73M
2025-06-30$46.40M$12.85M$10.06M$52.85M$62.91M$312.00K-$29.62M
2024-06-30$39.64M$10.25M$9.82M$49.72M$59.54M$270.00K-$29.07M
2023-06-30$31.73M$8.41M$9.96M$46.20M$56.16M$264.00K-$32.05M
2022-06-30$24.73M$6.21M$7.13M$41.48M$48.61M$107.00K-$30.47M
2021-06-30$21.45M$5.81M$6.54M$34.28M$40.82M$147.00K-$25.47M
2020-06-30$12.29M$5.63M$2.99M$21.30M$24.29M$143.00K-$19.07M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$67.90M$18.30M$14.91M$78.45M$93.36M$440.00K-$43.58M
2024-09-30$60.02M$15.61M$13.57M$75.13M$88.70M$462.00K-$43.22M
2023-09-30$49.40M$13.04M$14.18M$70.18M$84.37M$323.00K-$46.95M
2022-09-30$38.24M$9.56M$11.49M$61.20M$72.69M$107.00K-$44.64M
2021-09-30$34.71M$9.33M$9.36M$50.96M$60.32M$191.00K-$35.66M
2020-09-30$22.90M$8.78M$4.99M$32.11M$37.10M$192.00K-$22.93M
2019-09-30$22.25M$7.17M$4.45M$24.18M$28.63M$216.00K-$16.03M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$90.50M$23.36M$19.49M$101.31M$120.80M$626.00K-$54.00M
2024-12-31$83.79M$21.79M$17.57M$102.14M$119.70M$500.00K-$56.39M
2023-12-31$68.67M$17.92M$18.08M$94.61M$112.69M$571.00K-$60.84M
2022-12-31$53.66M$13.80M$15.40M$83.11M$98.50M$353.00K-$58.92M
2021-12-31$48.42M$12.79M$13.06M$69.87M$82.93M$343.00K-$48.66M
2020-12-31$32.73M$11.53M$7.46M$46.07M$53.53M$213.00K-$32.23M
2019-12-31$32.59M$10.18M$6.05M$34.20M$40.25M$363.00K-$20.70M
2018-12-31$20.00M$7.72M$6.99M$20.35M$27.34M$12.00K-$18.48M

Similar stocks

Stock NameCountryMarket CapPE Ratio
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Microbot Medical Inc. (MBOT)$0.089B-7.97
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B